Select Publications

Journal articles

Høilund-Carlsen PF; Alavi A; Barrio JR; Castellani RJ; Costa T; Herrup K; Kepp KP; Neve RL; Perry G; Revheim ME; Robakis NK; Sensi SL; Vissel B, 2024, 'Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village', Ageing Research Reviews, 93,

Wright AL; Konen LM; Mockett BG; Morris GP; Singh A; Burbano LE; Milham L; Hoang M; Zinn R; Chesworth R; Tan RP; Royle GA; Clark I; Petrou S; Abraham WC; Vissel B, 2023, 'The Q/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer’s disease', Molecular Neurodegeneration, 18,

Rentsch P; Egan T; Kuriakose A; Stayte S; Vissel B, 2023, 'The ratio of M1 to M2 microglia in the striatum determines the severity of L-Dopa-induced dyskinesias', Journal of Neurochemistry, 167, pp. 633 - 647,

Nair JD; Wilkinson KA; Yucel BP; Mulle C; Vissel B; Mellor J; Henley JM, 2023, 'GluK2 Q/R editing regulates kainate receptor signaling and long-term potentiation of AMPA receptors', iScience, 26,

Clark IA; Vissel B, 2023, 'Autocrine positive feedback of tumor necrosis factor from activated microglia proposed to be of widespread relevance in chronic neurological disease', Pharmacology Research and Perspectives, 11,

Kepp KP; Robakis NK; Høilund-Carlsen PF; Sensi SL; Vissel B, 2023, 'The amyloid cascade hypothesis: an updated critical review', Brain, 146, pp. 3969 - 3990,

Høilund-Carlsen PF; Revheim ME; Costa T; Alavi A; Kepp KP; Sensi SL; Perry G; Robakis NK; Barrio JR; Vissel B, 2023, 'Passive Alzheimer's immunotherapy: A promising or uncertain option?', Ageing Research Reviews, 90,

Dhungana A; Becchi S; Leake J; Morris G; Avgan N; Balleine BW; Vissel B; Bradfield LA, 2023, 'Goal-Directed Action Is Initially Impaired in a hAPP-J20 Mouse Model of Alzheimer’s Disease', eNeuro, 10,

Milham LT; Morris GP; Konen LM; Rentsch P; Avgan N; Vissel B, 2023, 'Quantification of AMPA receptor subunits and RNA editing-related proteins in the J20 mouse model of Alzheimer’s disease by capillary western blotting', Frontiers in Molecular Neuroscience, 16,

Kepp KP; Sensi SL; Johnsen KB; Barrio JR; Høilund-Carlsen PF; Neve RL; Alavi A; Herrup K; Perry G; Robakis NK; Vissel B; Espay AJ, 2023, 'The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes', Journal of Alzheimer's Disease, 94, pp. 497 - 507,

Abiero AR; Ali Z; Vissel B; Bradfield LA, 2022, 'Outcome-selective reinstatement is predominantly context-independent, and associated with c-Fos activation in the posterior dorsomedial striatum', Neurobiology of Learning and Memory, 187,

Krasne FB; Zinn R; Vissel B; Fanselow MS, 2021, 'Extinction and discrimination in a Bayesian model of context fear conditioning (BaconX)', Hippocampus, 31, pp. 790 - 814,

Leake J; Zinn R; Corbit LH; Fanselow MS; Vissel B, 2021, 'Engram size varies with learning and reflects memory content and precision', Journal of Neuroscience, 41, pp. 4120 - 4130,

Stayte S; Dhungana A; Vissel B; Bradfield LA, 2021, 'Parafascicular Thalamic and Orbitofrontal Cortical Inputs to Striatum Represent States for Goal-Directed Action Selection', Frontiers in Behavioral Neuroscience, 15,

Chen H; Wang B; Li G; Steele JR; Stayte S; Vissel B; Chan YL; Yi C; Saad S; Machaalani R; Oliver BG, 2021, 'Brain health is independently impaired by E-vaping and high-fat diet', Brain, Behavior, and Immunity, 92, pp. 57 - 66,

Clark IA; Vissel B, 2021, 'Broader insights into understanding tumor necrosis factor and neurodegenerative disease pathogenesis infer new therapeutic approaches', Journal of Alzheimer's Disease, 79, pp. 931 - 948,

Zinn R; Leake J; Krasne FB; Corbit LH; Fanselow MS; Vissel B, 2020, 'Maladaptive Properties of Context-Impoverished Memories', Current Biology, 30, pp. 2300 - 2311.e6,

Konen LM; Wright AL; Royle GA; Morris GP; Lau BK; Seow PW; Zinn R; Milham LT; Vaughan CW; Vissel B, 2020, 'A new mouse line with reduced GluA2 Q/R site RNA editing exhibits loss of dendritic spines, hippocampal CA1-neuron loss, learning and memory impairments and NMDA receptor-independent seizure vulnerability', Molecular Brain, 13,

Rentsch P; Stayte S; Egan T; Clark I; Vissel B, 2020, 'Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia', Neurobiology of Disease, 134,

Chia R; Zhong H; Vissel B; Edgerton VR; Gad P, 2020, 'Novel Activity Detection Algorithm to Characterize Spontaneous Stepping During Multimodal Spinal Neuromodulation After Mid-Thoracic Spinal Cord Injury in Rats', Frontiers in Systems Neuroscience, 13,

Carter A; Richards LJ; Apthorp D; Azghadi MR; Badcock DR; Balleine B; Bekkers JM; Berk M; Bourne JA; Bradley AP; Breakspear M; Brichta A; Carter O; Castles A; Chakli K; Cohen-Woods S; Conn SJ; Cornish J; Cornish K; de Zubicaray G; Egan GF; Enticott PG; Fitzgibbon BM; Forlini C; Fornito A; Griffiths L; Gullifer J; Hall W; Halliday G; Hannan AJ; Harrer S; Harvey A; Hatherly C; Hickie IB; Kennett J; Kiernan M; Kilpatrick T; Kiral-Kornek I; Korgaonkar MS; Lawrence AJ; Leventer R; Levy N; Licinio J; Lovell N; Mackellar G; Malcolm L; Mason A; Mattingley JB; Medland SE; Michie PT; Nithianantharajah J; Parker J; Payne JM; Poole-Warren L; Sah P; Sarnyai Z; Schofield PR; Shimoni O; Shum DHK; Silk T; Slee M; Smith AE; Soulis T; Sriram S; Stuart GJ; Tapson J; Thompson MB; van Schaik A; Vincent NA; Vissel B; Waters A, 2020, 'Erratum: A Neuroethics Framework for the Australian Brain Initiative (Neuron (2019) 101(3) (365–369), (S0896627319300054), (10.1016/j.neuron.2019.01.004))', Neuron, 105, pp. 201,

Stayte S; Laloli KJ; Rentsch P; Lowth A; Li KM; Pickford R; Vissel B, 2020, 'The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain', Experimental Neurology, 323,

Ma C; Jean-Richard-dit-Bressel P; Roughley S; Vissel B; Balleine B; Killcross S; Bradfield L, 2020, 'Medial Orbitofrontal Cortex Regulates Instrumental Conditioned Punishment, but not Pavlovian Conditioned Fear', ,

Ma C; Jean-Richard-Dit-Bressel P; Roughley S; Vissel B; Balleine BW; Killcross S; Bradfield LA, 2020, 'Medial Orbitofrontal Cortex Regulates Instrumental Conditioned Punishment, but not Pavlovian Conditioned Fear.', Cereb Cortex Commun, 1, pp. tgaa039,

Zhong H; Zhu C; Minegishi Y; Richter F; Zdunowski S; Roy RR; Vissel B; Gad P; Gerasimenko Y; Chesselet MF; Edgerton VR, 2019, 'Epidural Spinal Cord Stimulation Improves Motor Function in Rats With Chemically Induced Parkinsonism', Neurorehabilitation and Neural Repair, 33, pp. 1029 - 1039,

Clark IA; Vissel B, 2019, 'Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective–a Commentary', Expert Review of Neurotherapeutics, 19, pp. 535 - 543,

Rentsch P; Stayte S; Morris GP; Vissel B, 2019, 'Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on l-Dopa induced dyskinesia', BMC Neuroscience, 20,

Kennett J; Carter A; Bourne JA; Hall W; Levy N; Mattingley JB; Lawrence AJ; Forlini C; Malcolm L; Vincent N; Richards LJ; Egan GF; Breakspear M; Cornish K; Halliday G; Poole-Warren L; Sriram S; Soulis T; Fitzgibbon B; Kiral-Kornek I; Badcock DR; Balleine B; Bekkers JM; Berk M; Bradley A; Brichta A; Carter O; Castles A; Clements J; Cornish J; de Zubicaray G; Enticott PG; Fornito A; Griffiths L; Gullifer J; Hannan AJ; Harrer S; Harvey A; Hickie IB; Jazwinska L; Kiernan M; Kilpatrick T; Leventer R; Licinio J; Lovell N; Mackellar G; Medland SE; Michie PT; Nithianantharajah J; Parker J; Payne JM; Rossell S; Sah P; Sarnyai Z; Schofield PR; Shum DHK; Silk T; Slee M; Stuart GJ; Tapson J; van Schaik A; Vissel B; Waters A; Apthorp D; Cohen-Woods S; Conn SJ; Korgaonkar M; Mason A; Azghadi MR; Shimoni O; Smith A; Thompson MB, 2019, 'A Neuroethics Framework for the Australian Brain Initiative', Neuron, 101, pp. 365 - 369,

Chen H; Chan YL; Linnane C; Mao Y; Anwer AG; Sapkota A; Annissa TF; Herok G; Vissel B; Oliver BG; Saad S; Gorrie CA, 2018, 'L-Carnitine and extendin-4 improve outcomes following moderate brain contusion injury', Scientific Reports, 8,

Morris GP; Clark IA; Vissel B, 2018, 'Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease', Acta Neuropathologica, 136, pp. 663 - 689,

Clark IA; Vissel B, 2018, 'Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α-synuclein, amyloid-β and insulin resistance in neurodegenerative diseases', British Journal of Pharmacology, 175, pp. 3859 - 3875,

Clark IA; Vissel B, 2018, 'The inflammatory nature of post-surgical delirium predicts benefit of agents with anti-TNF effects, such as dexmedetomidine', Frontiers in Neuroscience, 12,

Mladenova D; Barry G; Konen LM; Pineda SS; Guennewig B; Avesson L; Zinn R; Schonrock N; Bitar M; Jonkhout N; Crumlish L; Kaczorowski DC; Gong A; Pinese M; Franco GR; Walkley CR; Vissel B; Mattick JS, 2018, 'Adar3 is involved in learning and memory in mice', Frontiers in Neuroscience, 12,

Burchfield JG; Kebede MA; Meoli CC; Stöckli J; Whitworth PT; Wright AL; Hoffman NJ; Minard AY; Ma X; Krycer JR; Nelson ME; Tan SX; Yau B; Thomas KC; Wee NKY; Khor EC; Enriquez RF; Vissel B; Biden TJ; Baldock PA; Hoehn KL; Cantley J; Cooney GJ; James DE; Fazakerley DJ, 2018, 'High dietary fat and sucrose results in an extensive and time-dependent deterioration in health of multiple physiological systems in mice', Journal of Biological Chemistry, 293, pp. 5731 - 5745,

Chan YL; Saad S; Machaalani R; Oliver BG; Vissel B; Pollock C; Jones NM; Chen H, 2017, 'Maternal cigarette smoke exposure worsens neurological outcomes in adolescent offspring with hypoxic-ischemic injury', Frontiers in Molecular Neuroscience, 10,

Clark IA; Vissel B, 2017, 'The meteorology of cytokine storms, and the clinical usefulness of this knowledge', Seminars in Immunopathology, 39, pp. 505 - 516,

Stayte S; Vissel B, 2017, 'New hope for devastating neurodegenerative disease', Brain, 140, pp. 1177 - 1179,

Leake J; Zinn R; Corbit L; Vissel B, 2017, 'Dissociation between complete hippocampal context memory formation and context fear acquisition', Learning and Memory, 24, pp. 153 - 157,

Stayte S; Rentsch P; Tröscher AR; Bamberger M; Li KM; Vissel B, 2017, 'Activin A inhibits MPTP and LPS-induced increases in inflammatory cell populations and loss of dopamine neurons in the mouse midbrain in Vivo', PLoS ONE, 12,

Clark IA; Vissel B, 2016, 'Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents', Journal of Neuroinflammation, 13,

Wright AL; Vissel B, 2016, 'CAST your vote: Is calpain inhibition the answer to ALS?', Journal of Neurochemistry, 137, pp. 140 - 141,

Morris GP; Wright AL; Tan RP; Gladbach A; Ittner LM; Vissel B, 2016, 'A comparative study of variables influencing ischemic injury in the longa and koizumi methods of intraluminal filament middle cerebral artery occlusion in mice', PLoS ONE, 11,

Clark IA; Vissel B, 2015, 'Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease', British Journal of Pharmacology, 172, pp. 3714 - 3727,

Stayte S; Rentsch P; Li KM; Vissel B, 2015, 'Activin a protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease', PLoS ONE, 10,

Clark IA; Vissel B, 2015, 'A Neurologist's Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in Disease', Neural Plasticity, 2015,

Clark IA; Vissel B, 2015, 'Amyloid β: One of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease', British Journal of Pharmacology,

Clark IA; Vissel B, 2014, 'Inflammation-sleep interface in brain disease: TNF, insulin, orexin', Journal of Neuroinflammation, 11,

Morris GP; Clark IA; Vissel B, 2014, 'Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease', Acta Neuropathologica Communications, 2,

Stayte S; Vissel B, 2014, 'Advances in non-dopaminergic treatments for Parkinson's disease', Frontiers in Neuroscience,

Stayte S; Vissel B, 2014, 'Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease', Frontiers in Neuroscience

Back to profile page